**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 7440-02-0 |Nickel | 0.1 | 231-111-4 |
|----------------|--------------------------------------|----------|-----------|
| 7697-37-2 |Nitric acid | 2.0 | 231-714-2 |
|----------------|--------------------------------------|----------|-----------|
| 7732-18-5 |Water | 97.9 | 231-791-2 |
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: XN
Risk Phrases: 37/38 40 41
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to respiratory system and skin. Limited evidence of a
carcinogenic effect. Risk of serious damage to eyes.
Potential Health Effects
Eye:
Contact with eyes may cause severe irritation, and possible eye
burns. May cause chemical conjunctivitis.
Skin:
Causes skin irritation. Causes "nickel itch" which is a dermatitis
resulting from sensitization to nickel, which is characterized by
skin eruptions, followed by discrete ulcers that may discharge and
become crusted, or by eczema.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea.
Inhalation:
Causes respiratory tract irritation. Can produce delayed pulmonary
edema.
Chronic:
Effects may be delayed. Symptoms of overexposure to nickel can cause
sensitization, dermatitis, allergic asthma and pneumonitis.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Use
extinguishing media appropriate to the surrounding fire. Substance is
noncombustible. Vapors may be heavier than air. They can spread
along the ground and collect in low or confined areas.
Extinguishing Media:
Substance is noncombustible; use agent most appropriate to
extinguish surrounding fire. Use water spray, dry chemical, carbon
dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Avoid runoff into storm sewers and
ditches which lead to waterways. Clean up spills immediately,
observing precautions in the Protective Equipment section. Provide
ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Avoid contact with eyes, skin, and
clothing. Keep container tightly closed. Avoid ingestion and
inhalation. Use with adequate ventilation. Wash clothing before
reuse.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 7440-02-0:
United Kingdom, WEL - TWA: 0.5 mg/m3 TWA
United Kingdom, WEL - STEL: 1.5 mg/m3 STEL
United States OSHA: 1 mg/m3 TWA
Belgium - TWA: 1 mg/m3 VLE
France - VME: 1 mg/m3 VME; 1 mg/m3 VME (metal gratings)
Germany: 0.5 mg/m3 TWA (inhalable fraction)
Japan: 1 mg/m3 OEL
Malaysia: 1.5 mg/m3 TWA (inhalable fraction)
Netherlands: 1 mg/m3 MAC
Russia: 0.05 mg/m3 TWA
Spain: 1 mg/m3 VLA-ED
CAS# 7697-37-2:
United Kingdom, WEL - TWA: 2 ppm TWA; 5.2 mg/m3 TWA
United Kingdom, WEL - STEL: 4 ppm STEL; 10 mg/m3 STEL
United States OSHA: 2 ppm TWA; 5 mg/m3 TWA
Belgium - TWA: 2 ppm VLE; 5.3 mg/m3 VLE
Belgium - STEL: 4 ppm VLE; 10 mg/m3 VLE
France - VME: 2 ppm VME; 5 mg/m3 VME
France - VLE: 4 ppm VLE; 10 mg/m3 VLE
Germany: 2 ppm TWA; 5.2 mg/m3 TWA
Japan: 2 ppm OEL; 5.2 mg/m3 OEL
Malaysia: 2 ppm TWA; 5.2 mg/m3 TWA
Netherlands: 0.5 ppm STEL; 1.3 mg/m3 STEL
Russia: 2 mg/m3 TWA
Spain: 2 ppm VLA-ED; 5.2 mg/m3 VLA-ED
Spain: 4 ppm VLA-EC; 10 mg/m3 VLA-EC
CAS# 7732-18-5:
Personal Protective Equipment
Eyes:
Wear chemical splash goggles.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: green to blue
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: miscible
Specific Gravity/Density:
Molecular Formula: Solution
Molecular Weight: 0
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Incompatible materials, excess heat.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, irritating and toxic fumes and gases, nitrogen.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 7440-02-0: QR5950000 QR6126100 QR6555000 QR7120000
CAS# 7697-37-2: QU5775000 QU5900000
CAS# 7732-18-5: ZC0110000
LD50/LC50:
Not available.
CAS# 7697-37-2: Inhalation, rat: LC50 = 260 mg/m3/30M; Inhalation,
rat: LC50 = 130 mg/m3/4H; Inhalation, rat: LC50 = 67 ppm(NO2)/4H.
CAS# 7732-18-5: Oral, rat: LD50 = >90 mL/kg.
Carcinogenicity:
Nickel -
California: carcinogen, initial date 10/1/89
NTP: Suspect carcinogen
IARC: Group 1 carcinogen (listed as Nickel compounds).
Nitric acid -
Not listed by ACGIH, IARC, or NTP.
Water -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: NITRIC ACID
Hazard Class: 8
UN Number: 2031
Packing Group: II
IMO
Shipping Name: NITRIC ACID
Hazard Class: 8
UN Number: 2031
Packing Group: II
RID/ADR
Shipping Name: NITRIC ACID
Hazard Class: 8
UN Number: 2031
Packing group: II
USA RQ: CAS# 7440-02-0: 100 lb final RQ (no reporting of releases of this hazard
USA RQ: CAS# 7697-37-2: 1000 lb final RQ; 454 kg final RQ
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 37/38 Irritating to respiratory system and skin.
R 40 Limited evidence of a carcinogenic effect.
R 41 Risk of serious damage to eyes.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37/39 Wear suitable gloves and eye/face
protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 7440-02-0: No information available.
CAS# 7697-37-2: 1
CAS# 7732-18-5: No information available.
Canada
CAS# 7440-02-0 is listed on Canada's DSL List.
CAS# 7697-37-2 is listed on Canada's DSL List.
CAS# 7732-18-5 is listed on Canada's DSL List.
CAS# 7440-02-0 is listed on Canada's Ingredient Disclosure List.
CAS# 7697-37-2 is listed on Canada's Ingredient Disclosure List.
CAS# 7732-18-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 7440-02-0 is listed on the TSCA inventory.
CAS# 7697-37-2 is listed on the TSCA inventory.
CAS# 7732-18-5 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
R 40 Limited evidence of a carcinogenic effect.
R 43 May cause sensitization by skin contact.
MSDS Creation Date: 9/02/1997 Revision #6 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
N-Propyl Acetate, 99+%
| 109-60-4 |
|
Rhodizonic acid dipotassium salt, 95% (uv-vis)
| 13021-40-4 |
|
delta-Valerolactone, 99%
| 542-28-9 |
|
Octaethylporphine
| 2683-82-1 |
|
(2r,4r)-(-)-pentanediol, 99%
| 42075-32-1 |
|
3'-Chloropropiophenone, 98%
| 34841-35-5 |
|
16-Doxyl-Stearic Acid, Free Radical
| 53034-38-1 |
|
(Trifluoromethoxy)benzene, 99+%
| 456-55-3 |
|
N-Butyramide 99%
| 541-35-5 |
|
O-Acetylmandelic acid chloride, 95%
| 1638-63-7 |
|
2-Ethylhexyl cyanoacetate, 98+%
| 13361-34-7 |
|
Pyruvic aldehyde dimethyl acetal, 98%
| 6342-56-9 |
|
1,1'-Diethyl-2,2'-Cyanine Iodide, 99% (UV-Vis)
| 977-96-8 |
|
Isophthaloyl dichloride, 98%
| 99-63-8 |
|
Dibutyltin diacetate, pract.
| 1067-33-0 |
|
Methyl cinnamate, 98%
| 103-26-4 |
|
L-Cystine Dimethyl Ester Dihydrochloride
| 32854-09-4 |
|
Corn Oil, U.S.P./N.F.
| 8001-30-7 |
|
3-Iodobenzylamine hydrochloride, 97%
| 3718-88-5 |
|
4-Phenoxyphenol, 99%
| 831-82-3 |
|
1,10-Phenanthroline monohydrochloride monohydrate, 97%
| 3829-86-5 |
|
Ethyl 3-N-Ethyl-Aminoacrylate
| 55330-56-8 |
|
Phenetole, 99%
| 103-73-1 |
|
Nickel atomic absorption standard solution, 1 mg/ml Ni in 2% HNO3
| 7440-02-0 |
|
Ethyl Glycolate, 95% (GC)
| 623-50-7 |
|
Magnesium Fluoride, 98+%
| 7783-40-6 |
|
Homovanillic Acid, 98%
| 306-08-1 |
|
(R,R)-(-)-1,2-Dicyclohexyl-1,2-Ethanediol, 99%
| 120850-92-2 |
|
Methyl nicotinate, 99%
| 93-60-7 |
|
D-(+)-Talose, 99%
| 2595-98-4 |
|
1,3-Phenylenediacetic acid, 97%
| 19806-17-8 |
|
Ethyl 4-bromocrotonate, tech., 75%
| 37746-78-4 |
|
(s)-(-)-alpha-(1-Naphtyl)ethylamine, 99+%,
| 10420-89-0 |
|
Homophthalic acid, 99%
| 89-51-0 |
|
p-Xylene-alpha,alpha,alpha,alpha',alpha',alpha'-d6, 99+ atom % D
| 106-42-3 |
|
Coumestrol, 99% (UV-Vis)
| 479-13-0 |
|
2-Amino-5-nitropyridine, 99%
| 4214-76-0 |
|
2-Amino-5-Chlorobenzoxazole, 97%
| 61-80-3 |
|
alpha-Naphtholphthalein, indicator
| 596-01-0 |
|
3-Picoline, 99.5+%
| 108-99-6 |
|
Chromium(vi) oxide pyridine complex
| 20492-50-6 |
|
N-Butylcarbamate, 97%
| 592-35-8 |
|
6-Bromo-7-Nitroquinoxaline, 95%
| 113269-09-3 |
|
n-2-Acetylguanine, 99+%
| 19962-37-9 |
|
1,2:5,6-Di-O-Isopropylidene-Alpha-D-Allofuranose, 98%
| 2595-05-3 |
|
N-Cyanoimido Dimethyl Carbonate, 95% (on Dry Substance)
| 0-00-1 |
|
l-(-)-Glyceraldehyde 90 wt% aqueous solution
| 497-09-6 |
|
5-Aminoisophthalic Acid, 98+%(Titr.; Dry Substance)
| 99-31-0 |
|
Flufenamic Acid, 97%
| 530-78-9 |
|
Lipase AY30, according to amano's specification
| 9001-62-1 |
|
|